- Home
- LUCY vs CELZ Comparison
LUCY vs CELZ Comparison
Compare LUCY & CELZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LUCY | CELZ |
|---|---|---|
| Founded | 2017 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Ophthalmic Goods | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.0M | 6.6M |
| IPO Year | N/A | 2008 |
Fundamental Metrics
Financial Performance| Metric | LUCY | CELZ |
|---|---|---|
| Price | $1.11 | $1.97 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 77.6K | 17.2K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 1.33 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $11,000.00 |
| Revenue This Year | $80.76 | N/A |
| Revenue Next Year | $210.34 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 22.22 |
| 52 Week Low | $0.95 | $1.50 |
| 52 Week High | $5.56 | $6.25 |
Technical Indicators
Market Signals| Indicator | LUCY | CELZ |
|---|---|---|
| Relative Strength Index (RSI) | 46.79 | 51.46 |
| Support Level | $0.98 | $1.76 |
| Resistance Level | $1.22 | $1.96 |
| Average True Range (ATR) | 0.07 | 0.07 |
| MACD | 0.01 | 0.02 |
| Stochastic Oscillator | 43.75 | 69.23 |
Price Performance
Historical ComparisonAbout LUCY Innovative Eyewear Inc.
Innovative Eyewear Inc is engaged in developing and selling eyeglasses and sunglasses, which are designed to allow customers to remain connected to their digital lives, while also offering prescription eyewear and sun protection. Its products include Lucyd Lyte, Nautica, Eddie Bauer, Lucyd Armor line, and Reebok.
About CELZ Creative Medical Technology Holdings Inc.
Creative Medical Technology Holdings Inc is a biotechnology holding company focused on regenerative medicine. It is formed for the purpose of creating and licensing intellectual property in the area of amniotic fluid derived stem cells for therapeutic applications. Its core activity is stem cell research and the development of applications for use to treat male and female sexual dysfunction, infertility, miscarriages, and related issues.